Home / PTCD2 Knockout Cell Lines

PTCD2 Knockout Cell Lines

Gene: PTCD2

Official Full Name: pentatricopeptide repeat domain 2provided by HGNC

Gene Summary: Enables RNA binding activity. Predicted to be involved in mitochondrion organization and regulation of mRNA processing. Predicted to act upstream of or within several processes, including liver development; muscle cell development; and ventricular cardiac muscle tissue morphogenesis. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO14807 PTCD2 Knockout cell line (HeLa) Human PTCD2 1:3~1:6 Negative Online Inquiry
KO14808 PTCD2 Knockout cell line (HCT 116) Human PTCD2 1:2~1:4 Negative Online Inquiry
KO14809 PTCD2 Knockout cell line (HEK293) Human PTCD2 1:3~1:6 Negative Online Inquiry
KO14810 PTCD2 Knockout cell line (A549) Human PTCD2 1:3~1:4 Negative Online Inquiry

Background

PTCD2 Gene Knockout Cell Lines are expertly engineered cellular models designed to investigate the functional role of the PTCD2 gene (pentatricopeptide repeat-containing protein 2) in various biological processes. By utilizing advanced CRISPR/Cas9 technology, these cell lines exhibit a complete knockout of the PTCD2 gene, allowing researchers to discern the gene's contributions to mitochondrial function, RNA processing, and oxidative stress responses.

The key function of the PTCD2 Gene Knockout Cell Lines lies in their ability to elucidate how the absence of PTCD2 influences cellular pathways, particularly those linked to mitochondrial dynamics and gene expression regulation. As a PPR-containing protein, PTCD2 is implicated in the stability of mitochondrial mRNA and rRNA, making these cell lines invaluable for detailed studies focused on mitochondrial biogenesis and metabolic regulation.

The scientific importance of these cell lines extends to both research and clinical applications. In research settings, they serve as a critical tool to explore disease models, contributing to our understanding of mitochondrial pathologies and genetic disorders. Clinically, they hold promise in identifying potential therapeutic targets for diseases linked with mitochondrial dysfunction, such as neurodegenerative conditions and metabolic syndromes.

What sets PTCD2 Gene Knockout Cell Lines apart from alternative models is their robustness and high specificity in gene targeting. Engineered with meticulous precision, these cell lines minimize off-target effects commonly seen in less sophisticated models, resulting in more reliable and reproducible data. Furthermore, they can be used in high-throughput screening assays, revealing insights rapidly and efficiently.

For researchers and clinicians alike, the PTCD2 Gene Knockout Cell Lines offer a compelling value proposition—they provide a clear mechanism to validate the role of PTCD2 in health and disease, ultimately leading to advancements in therapeutic strategies. Their application potential ensures that users can confidently explore the gene's biological significance.

Our company specializes in providing top-tier genetic products and services, backed by a team of experts dedicated to advancing molecular research. With a focus on cutting-edge innovation, our offerings are designed to empower scientists and healthcare professionals in their quest for discovery.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.